BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21796820)

  • 1. What mergers can do for you.
    Acharya A
    Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
    [No Abstract]   [Full Text] [Related]  

  • 2. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 3. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 4. This Dutchman is flying.
    Watson N
    Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 6. Showcasing bioscience in Rhode Island.
    Spero D
    R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyseq-Variagenics merger signals end of the line.
    Hodgson J
    Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
    [No Abstract]   [Full Text] [Related]  

  • 9. New IGF drug stirs competition in growth factor segment.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
    [No Abstract]   [Full Text] [Related]  

  • 10. Antisoma-Roche deal--a new kind of buyout?
    Mitchell P
    Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
    [No Abstract]   [Full Text] [Related]  

  • 11. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 12. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 13. How do you measure "success" in a biotechnology company?
    Greetham EM
    Nat Biotechnol; 1998 May; 16 Suppl():59-60. PubMed ID: 9591275
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 15. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 16. DPI delivers biotechnology superstore. Discovery Partners International.
    Glaser V
    Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
    [No Abstract]   [Full Text] [Related]  

  • 17. Deal watch: recent trends in deal-making.
    Dawkes A; Papp T
    Nat Rev Drug Discov; 2010 Dec; 9(12):909. PubMed ID: 21119724
    [No Abstract]   [Full Text] [Related]  

  • 18. Roche chases stake in medical sequencing.
    Hayden EC
    Nature; 2012 Apr; 484(7393):152. PubMed ID: 22498604
    [No Abstract]   [Full Text] [Related]  

  • 19. Take your partner by the hand..
    Smaglik P
    Nature; 2005 Jun; 435(7046):1281. PubMed ID: 15997477
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.